GRIP1
(Glutamate Receptor Interacting Protein 1 (GRIP1))
Spezies
Human, Maus
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
Produktmerkmale
This is a synthetic peptide designed for use in combination with anti-GRIP1 antibody (Catalog #: ARP32496_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
GRIP1
(Glutamate Receptor Interacting Protein 1 (GRIP1))
Hintergrund
GRIP1 is a steroid receptor coactivator family (SRC) member. SRC proteins comprise a well-characterized family of nuclear receptor (NR) coactivators that increase transcriptional activation by NRs via covalent modification of chromatin proteins and recruitment of other coactivators.
Protein Interaction Partner: AR,CSPG4,EFNB1,EFNB2,FLII,IRF3,NR3C1,PICK1,GRM7,TES,AR,CSPG4,GRIA1,GRIA2,GRIA3,GRIA4,GRIK1,GRIK2,GRIK3,GRIPAP1,GRM3,NR2F1,NUMBL,PRLHR